Showing results (1421-1430 of 1,532) with videos related to

Sort By:
Pageof 154
Chemical Science|February 15, 2020
Chronic exposure to complex metal oxide nanoparticles elicits rapid resistance in <i>Shewanella oneidensis</i> MR-1Stephanie L Mitchell, Natalie V Hudson-Smith, Meghan S Cahill, et al.
Current Oncology (Toronto, Ont.)|January 27, 2026
The CAnadian Network for Psychedelic-Assisted Cancer Therapy (CAN-PACT): A Multi-Phase Program OverviewLinda E Carlson, Harriet Richardson, Ron Shore, et al.
Molecular Systems Biology|April 24, 2016
Predictive features of ligand-specific signaling through the estrogen receptorJerome C Nwachukwu, Sathish Srinivasan, Yangfan Zheng, et al.
Human Molecular Genetics|February 8, 2017
Metformin pharmacogenomics: a genome-wide association study to identify genetic and epigenetic biomarkers involved in metformin anticancer response using human lymphoblastoid cell linesNifang Niu, Tongzheng Liu, Junmei Cairns, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|January 6, 2021
Patient and family financial burden associated with cancer treatment in Canada: a national studyChristopher J Longo, Margaret I Fitch, Jonathan M Loree, et al.
European Journal of Pharmacology|November 4, 2010
Cannabinoid CB(1) receptor ligand binding and function examined through mutagenesis studies of F200 and S383Doree F Sitkoff, Ning Lee, Bruce A Ellsworth, et al.
Elife|February 3, 2016
Estrogen receptor alpha somatic mutations Y537S and D538G confer breast cancer endocrine resistance by stabilizing the activating function-2 binding conformationSean W Fanning, Christopher G Mayne, Venkatasubramanian Dharmarajan, et al.
Plant Molecular Biology|August 18, 2006
EST database for early flower development in California poppy (Eschscholzia californica Cham., Papaveraceae) tags over 6,000 genes from a basal eudicotJohn E Carlson, James H Leebens-Mack, P Kerr Wall, et al.
The Journal of Infectious Diseases|May 16, 2022
Real-World Evidence of the Neutralizing Monoclonal Antibody Sotrovimab for Preventing Hospitalization and Mortality in COVID-19 OutpatientsNeil R Aggarwal, Laurel E Beaty, Tellen D Bennett, et al.
BMC Infectious Diseases|November 7, 2022
Association between treatment failure and hospitalization after receipt of neutralizing monoclonal antibody treatment for COVID-19 outpatientsDavid J Douin, Adane F Wogu, Laurel E Beaty, et al.
Pageof 154